Urolithiasis and the risk of ESRD
- PMID: 22745275
- PMCID: PMC3430957
- DOI: 10.2215/CJN.03210312
Urolithiasis and the risk of ESRD
Abstract
Background and objectives: The contribution of urolithiasis, if any, to the development of ESRD is unclear.
Design, setting, participants, & measurements: All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System.
Results: Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95% confidence interval: 1.45-3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95% confidence interval: 1.09-3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1% based on a prevalence of 5.4% for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44% versus 4%), recurrent urinary tract infections (26% versus 4%), acquired single kidney (15% versus 3%), neurogenic bladder (12% versus 1%), and ileal conduit (9% versus 0%), but not diabetes (32% versus 49%) or hypertension (44% versus 52%).
Conclusions: Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.
Figures

Similar articles
-
Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23. Am J Kidney Dis. 2018. PMID: 30146423 Free PMC article.
-
Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.Clin J Am Soc Nephrol. 2017 Mar 7;12(3):476-482. doi: 10.2215/CJN.06600616. Epub 2017 Feb 1. Clin J Am Soc Nephrol. 2017. PMID: 28148559 Free PMC article.
-
Kidney stones and the risk for chronic kidney disease.Clin J Am Soc Nephrol. 2009 Apr;4(4):804-11. doi: 10.2215/CJN.05811108. Epub 2009 Apr 1. Clin J Am Soc Nephrol. 2009. PMID: 19339425 Free PMC article.
-
Nephrolithiasis and loss of kidney function.Curr Opin Nephrol Hypertens. 2013 Jul;22(4):390-6. doi: 10.1097/MNH.0b013e32836214b9. Curr Opin Nephrol Hypertens. 2013. PMID: 23736840 Free PMC article. Review.
-
Chronic kidney disease in kidney stone formers.Clin J Am Soc Nephrol. 2011 Aug;6(8):2069-75. doi: 10.2215/CJN.10651110. Epub 2011 Jul 22. Clin J Am Soc Nephrol. 2011. PMID: 21784825 Free PMC article. Review.
Cited by
-
Oxalate Alters Cellular Bioenergetics, Redox Homeostasis, Antibacterial Response, and Immune Response in Macrophages.Front Immunol. 2021 Oct 21;12:694865. doi: 10.3389/fimmu.2021.694865. eCollection 2021. Front Immunol. 2021. PMID: 34745086 Free PMC article.
-
Safety and efficacy of a polyherbal formulation from traditional Persian medicine in patients with calcium kidney stones: A randomized, double-blinded clinical trial.J Res Med Sci. 2024 Feb 23;29:12. doi: 10.4103/jrms.jrms_670_22. eCollection 2024. J Res Med Sci. 2024. PMID: 38524751 Free PMC article.
-
Hydration for Adult Patients with Nephrolithiasis: Specificities and Current Recommendations.Nutrients. 2023 Nov 22;15(23):4885. doi: 10.3390/nu15234885. Nutrients. 2023. PMID: 38068743 Free PMC article. Review.
-
Practice patterns of kidney stone management across European and non-European centers: an in-depth investigation from the European Renal Stone Network (ERSN).J Nephrol. 2021 Aug;34(4):1337-1346. doi: 10.1007/s40620-020-00854-6. Epub 2020 Sep 12. J Nephrol. 2021. PMID: 32918723 Free PMC article.
-
Trends in the prevalence of kidney stones in the United States from 2007 to 2016.Urolithiasis. 2021 Feb;49(1):27-39. doi: 10.1007/s00240-020-01210-w. Epub 2020 Sep 1. Urolithiasis. 2021. PMID: 32870387
References
-
- Gillen DL, Worcester EM, Coe FL: Decreased renal function among adults with a history of nephrolithiasis: A study of NHANES III. Kidney Int 67: 685–690, 2005 - PubMed
-
- Vupputuri S, Soucie JM, McClellan W, Sandler DP: History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14: 222–228, 2004 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous